Skip Navigation
Headquarters
Knoxville, TN
Status
Exits
Investment Year
1999

CTI is a leading supplier of products and services for positron emission tomography (PET), a diagnostic imaging technology used in the detection and treatment of cancer, cardiac disease and neurological disorders. Products and services include scanners, cyclotrons and radiopharmaceuticals. Pamlico initially invested in CTI in 1999 and exited following the company’s initial public offering in 2004.

Investment Team